Janux Therapeutics, cancer immunotherapy, $125M Series B with Ra Capital, Avalon Ventures, Orbimed
Classy, non-profit SaaS, $118M Series D with Norwest Venture Partners, Salesforce Ventures, Hinge Capital, Santa Barbara Venture Partners
Kandji, device management platform, $60M Series B with Okta Ventures, First Round Capital, SVB Capital, Felicis Ventures
Shoreline Biosciences, cancer immunotherapy, $43M with Boxer Capital
Molecular Assemblies, DNA synthesis, $24M Series A with Keshif Ventures, Alexandria Venture Investments, iSelect Fund
Seqster, health data management, $12M Series A with Anne Wojcicki (23andMe), Takeda Ventures
Rejuvenate Bio, aging gene therapy, $10M Series A with Digitalis Ventures, Kendall Capital Partners
Yembo, AI for video asset management, $8.5M Series A with Imogen Capital Partners